Speclipse Company
Speclipse is a transformative, patented technology for real-time, non-invasive, in-vivo cancer diagnosis utilizing laser spectroscopy and machining learning algorithms.
Last Funding Date:
2021-08-19
Total Funding:
10243846
Founded Date:
2015-01-01
Headquarters:
Seongnam,Kyonggi-do,South Korea,Asia
Employee Number:
11-50
Funding Status:
private
Industry:
Thermometry
Super Industry:
Quantum Sensing
Funding Total Value:
10243846
Last Funding Total Usd:
7700000
Last Funding Total Currency:
USD
Last Funding Total Value:
7700000
Founders:
Sung Hyun Pyun,Wanki Min
Phone Number:
82-31-698-2269